Back
Azimut Holding SPA Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
58
AZIHF
Azimut Holding SPA
Last Price:
25.19
Seasonality Move:
-3.3%
Sell
43
RARE
Ultragenyx Pharmaceutical
Last Price:
39.82
Seasonality Move:
-0.9%
Buy
58
Azimut Holding SPA (AZIHF)
is a Buy
Is Azimut Holding SPA a Buy, Sell or Hold?
- The current Azimut Holding SPA [AZIHF] share price is $25.29. The Score for AZIHF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- AZIHF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AZIHF Stock Price Chart
What is Azimut Holding SPA's stock price today?
-
The Azimut Holding SPA share price today is $25.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AZIHF is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $39.39
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
AZIHF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.57 | Sell |
| Relative Strength Index (14 RSI): | 28.2 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.08 - 28.4) | Sell |
| Bollinger Bands (100): | (26.36 - 28.98) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.74 | Sell |
| Relative Strength Index (14 RSI): | 45.16 | Sell |
| Chaikin Money Flow: | -377368 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.89 - 42.13) | Sell |
| Bollinger Bands (100): | (40.93 - 48.81) | Sell |
AZIHF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.82 | Sell |
| 20-day SMA: | 26.91 | Sell |
| 50-day SMA: | 26.92 | Sell |
| 200-day SMA: | 25.43 | Sell |
| 8-day EMA: | 25.78 | Sell |
| 20-day EMA: | 26.52 | Sell |
| 50-day EMA: | 26.97 | Sell |
| 200-day EMA: | 25.81 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.13 | Sell |
| 20-day SMA: | 40.38 | Sell |
| 50-day SMA: | 41.72 | Sell |
| 200-day SMA: | 42.46 | Sell |
| 8-day EMA: | 39.68 | Sell |
| 20-day EMA: | 40.43 | Sell |
| 50-day EMA: | 41.92 | Sell |
| 200-day EMA: | 43.42 | Sell |
Azimut Holding SPA Earnings Growth & AZIHF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
Azimut Holding SPA Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||